Thuy Ho

Statistics

Publications

Citations

369

H-Index

Active since

2004

Affiliations

BD Biosciences (United States)(Current)

Takeda (United States)

Corning (United States)

Thuy Ho is an author at BD Biosciences (United States) specializing in pharmacology, cytochrome p450 enzymes, and cytochrome p450-mediated metabolism.

Publications per year

2004–2021

Publications

HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE

David M. Stresser, Marc I. Broudy, Thuy Ho et al. · Drug Metabolism and Disposition · 2004 · 128 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50shift approach facilitateskinactassay design

Elke S. Perloff, Andrew K. Mason, Shangara S. Dehal et al. · Xenobiotica · 2009 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +17

HUMAN CYTOCHROME P450 INDUCTION AND INHIBITION POTENTIAL OF CLEVIDIPINE AND ITS PRIMARY METABOLITE H152/81

George Zhang, Shangara S. Dehal, Thuy Ho et al. · Drug Metabolism and Disposition · 2006 · 40 citations

Medicine, Pharmacokinetics, Pharmacology +17

Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes

George Zhang, Thuy Ho, Alanna L. Callendrello et al. · Drug Metabolism and Disposition · 2014 · 31 citations

Medicine, Pharmacology, Toxicology +15

A Multi-Endpoint Evaluation of Cytochrome P450 1A2, 2B6 and 3A4 Induction Response in Human Hepatocyte Cultures After Treatment with &#946; - Naphthoflavone, Phenobarbital and Rifampicin

George Zhang, Thuy Ho, Alanna L. Callendrello et al. · Drug Metabolism Letters · 2010 · 30 citations

Medicine, Pharmacology, Toxicology +17

1–5 of 8